BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12065568)

  • 1. T helper cell activation in B-cell lymphomas.
    Bosshart H
    J Clin Oncol; 2002 Jun; 20(12):2904-5; author reply 2905. PubMed ID: 12065568
    [No Abstract]   [Full Text] [Related]  

  • 2. Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.
    Ansell SM; Stenson M; Habermann TM; Jelinek DF; Witzig TE
    J Clin Oncol; 2001 Feb; 19(3):720-6. PubMed ID: 11157023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help.
    French RR; Chan HT; Tutt AL; Glennie MJ
    Nat Med; 1999 May; 5(5):548-53. PubMed ID: 10229232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of autologous cytotoxic CD4+ T clones in a human model of B-cell non-Hodgkin follicular lymphoma.
    Mi JQ; Manches O; Wang J; Perron P; Weisbuch S; Marche PN; Renversez JC; Bensa JC; Sotto JJ; Cahn JY; Leroux D; Bonnefoix T
    Br J Haematol; 2006 Nov; 135(3):324-35. PubMed ID: 16984392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells.
    Torimoto Y; Sugita K; Weinberg DS; Dang NH; Donahue C; Letvin NL; Schlossman SF; Morimoto C
    J Immunol; 1991 Apr; 146(7):2176-84. PubMed ID: 1706389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity in Wegener's granulomatosis: characterizing T lymphocytes.
    Berden AE; Kallenberg CG; Savage CO; Yard BA; Abdulahad WH; de Heer E; Bruijn JA; Bajema IM
    Arthritis Rheum; 2009 Jun; 60(6):1578-87. PubMed ID: 19479864
    [No Abstract]   [Full Text] [Related]  

  • 7. CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes.
    Vauchy C; Gamonet C; Ferrand C; Daguindau E; Galaine J; Beziaud L; Chauchet A; Henry Dunand CJ; Deschamps M; Rohrlich PS; Borg C; Adotevi O; Godet Y
    Int J Cancer; 2015 Jul; 137(1):116-26. PubMed ID: 25449106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of B-cell lymphoma growth in syngeneic SJL/J mice. establishment of tumor dormancy following administration of anti-CD4 monoclonal antibody into tumor-bearing mice.
    Ohnishi K; Bonavida B
    Leukemia; 1993 Nov; 7(11):1801-6. PubMed ID: 8231249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T helper cell regulation of normal and neoplastic B cell growth.
    Snow EC; Pittner B; Reid S
    Semin Immunol; 1994 Oct; 6(5):311-26. PubMed ID: 7865801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile?
    Drent M; Grutters JC; Mulder PG; van Velzen-Blad H; Wouters EF; van den Bosch JM
    Sarcoidosis Vasc Diffuse Lung Dis; 1997 Mar; 14(1):31-8. PubMed ID: 9186987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1F7, a novel cell surface molecule, involved in helper function of CD4 cells.
    Morimoto C; Torimoto Y; Levinson G; Rudd CE; Schrieber M; Dang NH; Letvin NL; Schlossman SF
    J Immunol; 1989 Dec; 143(11):3430-9. PubMed ID: 2479677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugate.
    Montgomery AM; Wing MG; Lachmann PJ
    Immunology; 1992 Feb; 75(2):217-23. PubMed ID: 1532376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ cutaneous T-cell lymphomas show the phenotype of helper/inducer T cells (CD45RA-, CDw29+).
    Sterry W; Mielke V
    J Invest Dermatol; 1989 Sep; 93(3):413-6. PubMed ID: 2527911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
    Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G
    Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programming perpetual T helper cell plasticity.
    Rowell E; Wilson CB
    Immunity; 2009 Jan; 30(1):7-9. PubMed ID: 19144312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
    List AF; Spier CM; Miller TP; Grogan TM
    Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological role of helper T-cell subsets in helminth infections.
    King CL; Nutman TB
    Chem Immunol; 1992; 54():136-65. PubMed ID: 1358109
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunology. The yin and yang of follicular helper T cells.
    Awasthi A; Kuchroo VK
    Science; 2009 Aug; 325(5943):953-5. PubMed ID: 19696339
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional heterogeneity of CD4+ T lymphocytes: two subpopulations with counteracting immunoregulatory functions identified with the monoclonal antibodies WR16 and WR19.
    Moore K; Nesbitt AM
    Immunology; 1987 Jun; 61(2):159-65. PubMed ID: 2954898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.